Ohcanbohtosat - Vaknin-Dembinsky, Adi

Aiddostahte ozu
  1. 1
    COVID-19 in Cladribine-treated patient with multiple sclerosis

    COVID-19 in Cladribine-treated patient with multiple sclerosis Dahkki Haham, Nitsan, Vaknin-Dembinsky, Adi

    Almmustuhtton 2021
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    Effects of Supermagnetic Iron Oxide Labeling on the Major Functional Properties of Human Mesenchymal Stem Cells from Multiple Sclerosis Patients

    Effects of Supermagnetic Iron Oxide Labeling on the Major Functional Properties of Human Mesenchymal Stem Cells from Multiple Sclerosis Patients Dahkki Kassis, Ibrahim, Vaknin-Dembinsky, Adi, Bulte, Jeff, Karussis, Dimitrios

    Almmustuhtton 2010
    Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    Neuroinflammation Modulation via α7 Nicotinic Acetylcholine Receptor and Its Chaperone, RIC-3

    Neuroinflammation Modulation via α7 Nicotinic Acetylcholine Receptor and Its Chaperone, RIC-3 Dahkki Mizrachi, Tehila, Vaknin-Dembinsky, Adi, Brenner, Talma, Treinin, Millet

    Almmustuhtton 2021
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  4. 4
    Membrane bound IL-15 is increased on CD14 monocytes in early stages of MS

    Membrane bound IL-15 is increased on CD14 monocytes in early stages of MS Dahkki Vaknin-Dembinsky, Adi, Brass, Steven, Gandhi, Roopali, Weiner, Howard L.

    Almmustuhtton 2008
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  5. 5
    Blood Levels of Co-inhibitory-Receptors: A Biomarker of Disease Prognosis in Multiple Sclerosis

    Blood Levels of Co-inhibitory-Receptors: A Biomarker of Disease Prognosis in Multiple Sclerosis Dahkki Lavon, Iris, Heli, Coral, Brill, Livnat, Charbit, Hanna, Vaknin-Dembinsky, Adi

    Almmustuhtton 2019
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  6. 6
    Increased IL-23 secretion and altered chemokine production by dendritic cells upon CD46 activation in patients with multiple sclerosis

    Increased IL-23 secretion and altered chemokine production by dendritic cells upon CD46 activation in patients with multiple sclerosis Dahkki Vaknin-Dembinsky, Adi, Murugaiyan, Gopal, Hafler, David A., Astier, Anne L., Weiner, Howard L.

    Almmustuhtton 2008
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  7. 7
    Interferon-beta Inhibits Toll-Like Receptor 9 Processing in Multiple Sclerosis

    Interferon-beta Inhibits Toll-Like Receptor 9 Processing in Multiple Sclerosis Dahkki Balashov, Konstantin E., Aung, Latt Latt, Vaknin-Dembinsky, Adi, Dhib-Jalbut, Suhayl, Weiner, Howard L.

    Almmustuhtton 2010
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  8. 8
    Description of 3 patients with myasthenia gravis and COVID-19

    Description of 3 patients with myasthenia gravis and COVID-19 Dahkki Rein, Netaniel, Haham, Nitzan, Orenbuch-Harroch, Efrat, Romain, Marc, Argov, Zohar, Vaknin-Dembinsky, Adi, Gotkine, Marc

    Almmustuhtton 2020
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  9. 9
    Effect of cladribine on COVID-19 serology responses following two doses of the BNT162b2 mRNA vaccine in patients with multiple sclerosis

    Effect of cladribine on COVID-19 serology responses following two doses of the BNT162b2 mRNA vaccine in patients with multiple sclerosis Dahkki Brill, Livnat, Rechtman, Ariel, Zveik, Omri, Haham, Nitzan, Levin, Netta, Shifrin, Alla, Rozenberg, Ayal, Vaknin-Dembinsky, Adi

    Almmustuhtton 2022
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  10. 10
    Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course

    Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course Dahkki Rechtman, Ariel, Brill, Livnat, Zveik, Omri, Uliel, Benjamin, Haham, Nitzan, Bick, Atira S., Levin, Netta, Vaknin-Dembinsky, Adi

    Almmustuhtton 2022
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  11. 11
    Sera of Neuromyelitis Optica Patients Increase BID-Mediated Apoptosis in Astrocytes

    Sera of Neuromyelitis Optica Patients Increase BID-Mediated Apoptosis in Astrocytes Dahkki Zveik, Omri, Rechtman, Ariel, Haham, Nitzan, Adini, Irit, Canello, Tamar, Lavon, Iris, Brill, Livnat, Vaknin-Dembinsky, Adi

    Almmustuhtton 2022
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  12. 12
    Cerebrospinal fluid of progressive multiple sclerosis patients reduces differentiation and immune functions of oligodendrocyte progenitor cells

    Cerebrospinal fluid of progressive multiple sclerosis patients reduces differentiation and immune functions of oligodendrocyte progenitor cells Dahkki Zveik, Omri, Fainstein, Nina, Rechtman, Ariel, Haham, Nitzan, Ganz, Tal, Lavon, Iris, Brill, Livnat, Vaknin‐Dembinsky, Adi

    Almmustuhtton 2022
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  13. 13
    Circulating microRNAs as biomarkers for rituximab therapy, in neuromyelitis optica (NMO)

    Circulating microRNAs as biomarkers for rituximab therapy, in neuromyelitis optica (NMO) Dahkki Vaknin-Dembinsky, Adi, Charbit, Hanna, Brill, Livnat, Abramsky, Oded, Gur-Wahnon, Devorah, Ben-Dov, Iddo Z., Lavon, Iris

    Almmustuhtton 2016
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  14. 14
    Effectiveness of multi-disciplinary rehabilitation for patients with Neuromyelitis Optica

    Effectiveness of multi-disciplinary rehabilitation for patients with Neuromyelitis Optica Dahkki Nechemia, Yael, Moreh, Elior, Weingarden, Harold, Bloch, Ayala, Givon, Uri, Vaknin-Dembinsky, Adi, Schwartz, Isabella, Meiner, Zeev, Zeilig, Gabi

    Almmustuhtton 2016
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  15. 15
    Suppression of neuroinflammation by an allosteric agonist and positive allosteric modulator of the α7 nicotinic acetylcholine receptor GAT107

    Suppression of neuroinflammation by an allosteric agonist and positive allosteric modulator of the α7 nicotinic acetylcholine receptor GAT107 Dahkki Mizrachi, Tehila, Marsha, Oshrit, Brusin, Karen, Ben-David, Yael, Thakur, Ganesh A., Vaknin-Dembinsky, Adi, Treinin, Millet, Brenner, Talma

    Almmustuhtton 2021
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  16. 16
    Severe Acute Respiratory Syndrome Coronavirus 2 Third Vaccine Immune Response in Multiple Sclerosis Patients Treated with Ocrelizumab

    Severe Acute Respiratory Syndrome Coronavirus 2 Third Vaccine Immune Response in Multiple Sclerosis Patients Treated with Ocrelizumab Dahkki Brill, Livnat, Raposo, Catarina, Rechtman, Ariel, Zveik, Omri, Levin, Netta, Oiknine‐Djian, Esther, Wolf, Dana G., Vaknin‐Dembinsky, Adi

    Almmustuhtton 2022
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  17. 17
    Longitudinal humoral response in MS patients treated with cladribine tablets after receiving the second and third doses of SARS-CoV-2 mRNA vaccine()

    Longitudinal humoral response in MS patients treated with cladribine tablets after receiving the second and third doses of SARS-CoV-2 mRNA vaccine() Dahkki Brill, Livnat, Rechtman, Ariel, Shifrin, Alla, Rozenberg, Ayal, Afanasiev, Svetlana, Zveik, Omri, Haham, Nitzan, Levin, Neta, Vaknin-Dembinsky, Adi

    Almmustuhtton 2022
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  18. 18
    NMO-IgG and AQP4 Peptide Can Induce Aggravation of EAMG and Immune-Mediated Muscle Weakness

    NMO-IgG and AQP4 Peptide Can Induce Aggravation of EAMG and Immune-Mediated Muscle Weakness Dahkki Mizrachi, Tehila, Brill, Livnat, Rabie, Malcolm, Nevo, Yoram, Fellig, Yakov, Zur, Mayan, Karussis, Dimitrios, Abramsky, Oded, Brenner, Talma, Vaknin-Dembinsky, Adi

    Almmustuhtton 2018
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  19. 19
    Age-Related Clinical Presentation of MOG-IgG Seropositivity in Israel

    Age-Related Clinical Presentation of MOG-IgG Seropositivity in Israel Dahkki Brill, Livnat, Ganelin-Cohen, Esther, Dabby, Ron, Rabinowicz, Shira, Zohar-Dayan, Efrat, Rein, Netaniel, Aloni, Eyal, Karmon, Yuval, Vaknin-Dembinsky, Adi

    Almmustuhtton 2021
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  20. 20
    Humoral and T-Cell Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With Ocrelizumab

    Humoral and T-Cell Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With Ocrelizumab Dahkki Brill, Livnat, Rechtman, Ariel, Zveik, Omri, Haham, Nitzan, Oiknine-Djian, Esther, Wolf, Dana G., Levin, Netta, Raposo, Catarina, Vaknin-Dembinsky, Adi

    Almmustuhtton 2021
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: